US Federal Circuit Pauses Teva, Apotex After Hetlioz Patent Win

Vanda’s Tasimelteon Molecule Patent Expired ‘Just Last Week’

 
• By Dean Rudge

Teva and Apotex must put their plans to launch generic versions of Vanda’s Hetlioz on ice after the originator was granted – for now – a small injunction against the ANDA sponsors.

Pause video VHS
Vanda strongly challenged the lower court's findings • Source: Vegorus

More from Legal & IP

More from Generics Bulletin